Tag Archives | chemotherapy

Cipla collaborates with American Cancer Society to increase access to cancer treatment in Africa

Cipla Ltd, the global pharmaceutical company and owner of Cipla Medpro, South Africa’s third-largest pharmaceutical manufacturer, announced a ground-breaking market access agreement with the American Cancer Society (ACS), the Clinton Health Access Imitative (CHAI) and the pharmaceutical company Pfizer, to expand access to 16 essential cancer treatment medications, including chemotherapies, into Ethiopia, Nigeria, Kenya, Uganda, […]

Continue Reading · 0

Postmenopausal osteoporosis

Osteoporosis is a skeletal disorder characterised by compromised bone strength predisposing to an increased risk of fracture and is the major underlying cause of fractures in postmenopausal women and the elderly. (more…)

Continue Reading · 0

Integrative medicine’s role in oncology

Prof Burke has spent most of his life studying cancer, its causes and detection and his research tools are used globally. He is Emeritus Professor of Pharmaceutical Metabolism at Sunderland University after serving there as Dean of Science. (more…)

Continue Reading · 0

Management of Hepatocellular Cancer

Dr Daniel Rens Following on from the September edition forum article on hepatocellular carcinoma (HCC), which looked at the clinical presentation and diagnosis of the condition, this article focuses on its treatment and management. HCC is the most common form of primary liver cancer, and is responsible for approximately 500 000 global deaths per year. […]

Continue Reading · 0

Bladder Preservation in Invasive Bladder Cancer

Dr Marc Maurel Bladder cancer is the most common cancer affecting the urinary tract. Transitional cell (urothelial) carcinoma accounts for about 90% of cases. The average age at presentation is approximately 70 years and known predisposing factors include smoking and occupational carcinogen exposure. Prognosis The early stage of bladder cancer – nonmuscle invasive disease – […]

Continue Reading · 0

Difficulties in Managing Epithelial Ovarian Cancer

Dr Daniel Rens Mortality from ovarian cancer has remained high, despite efforts to improve prognosis, through early detection, advances in surgical techniques and more effective chemotherapy. There has been an ongoing lack of effective screening tools for early disease, resulting in a high percentage of patients already suffering from advanced stage disease at diagnosis. Ovarian […]

Continue Reading · 0